# Allopurinol Add-on Treatment for Refractory Mania

> **NCT00643123** · PHASE4 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Bipolar Disorder
- Mixed Mania
- Treatment-Resistant Mania

## Interventions

- **DRUG:** Allopurinol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00643123
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643123, "Allopurinol Add-on Treatment for Refractory Mania". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00643123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*